Cigna deal gets antitrust nod, positive sign for CVS/Aetna

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PCVX
2. PTC
3. NVDA
4. SPY
5. META
6. MSFT
7. GMAB
8. BBIO
9. BETR
10. USO

Go back to Cigna deal gets antitrust nod, positive sign for CVS/Aetna

Piper Jaffray Reiterates Overweight on Cigna Corp. (CI) Following Acquisition Approval

September 18, 2018 7:13 AM EDT

Piper Jaffray analyst, Sarah James, reiterated an Overweight rating and $215.00 price target on CIGNA (NYSE: CI) following the company's announcement that they have received DOJ approval for the ESRX acquisition. The deal is expected to closed by the end of the year.... More